Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk -- Ignore unavailable to you. Want to Upgrade?

To: h_ who wrote (186433)	2/19/2023 12:06:18 AM
From: TigerPaw	Read Replies (1) \| Respond to of 207884

so the actual cause of death is not necessarily known, regardless of what is reported So why do you "experts" trot out these implied sudden deaths when you admit you have no idea what you are writing about? I'm guessing you get a list of names to toss out by the lobby group for the loser pharma companies. Based on performance that is likely GlaxoSmithKline, Merck, and Sanofi Pasteur. Those are the companies that are way behind in the race for bio-technology and stand to lose a lot of business if the MRNA methods are extended to other treatments. So how do you get on their payroll? Do they troll the tin-foil blogs to find willing puppets ? How much do they pay?